IPO Trending
SOTACSME / NSEListed
Sotac Pharmaceuticals

Incorporated in 2015, Sotac Pharmaceuticals Limited, part of the Gujarat-based SOTAC Group, is engaged in manufacturing pharmaceutical products for various marketers on a loan license and contract manufacturing basis. Serving over 162 corporate clients, the company operates primarily on a principal-to-principal model. Established in 2017, its manufacturing facility has an annual capacity of 90 crore tablets and 14 crore capsules. Backed by promoters with over 59 years of combined industry experience, Sotac Pharmaceuticals continues to expand and strengthen its presence in the pharmaceutical sector.

₹105 - ₹1111.6x sub
Listed Price₹115.00
Listing Gain+3.60%

Subscription Status

1.6xTotal Demand
Updated 20 Oct 2026, 01:30 AM
Subscription PendingExchange subscription breakup is not available yet.

Category-wise demand has not been published yet. Check back after the exchange updates the live subscription feed.

Open Date29 Mar 2023
Close Date03 Apr 2023
Listing Date13 Apr 2023
Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Sotac Pharmaceuticals IPO Subscription Demand

Live subscription status and bidding analysis for Sotac Pharmaceuticals (SOTAC) IPO. The issue is subscribed 1.6x overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.

Frequently Asked Questions